Prescription Drug Market
Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials testified at a… read more
Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials testified at a hearing on prescription drug cost increases. The CEOs explained the rationale behind the increases and other factors affecting market competition. Martin Shkreli, who received widespread attention when his former Turing Pharmaceuticals company obtained the license for the drug Daraprim and raised its price by over 5,000 percent, declined to answer questions and exercised his Fifth Amendment right against self-incrimination. The FDA officials described the backlog of generic drug applications and what they are doing to expedite the review process. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
-
-
-
-
-
-
-
-
-
-
- Jody B. Hice U.S. Representative [R] Georgia
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- Martin Shkreli Founder and CEO (Former) Turing Pharmaceuticals
-
Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
Featured Clips from This Video
-
Martin Shkreli Pleads the Fifth
Former Turing Pharmaceuticals CEO Martin Shkreli invokes the Fifth Amendment and refuses to testify at a House hearing…
- 10 minutes
- 95,902 views
Related Video
-
Generic Drug Approval Process and Accessibility
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the…
-
Generic Drug Marketplace
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also…
-
News of the Day
An update on news of the day included an investigation into pharmaceutical price-fixing.
-
Representatives Cummings and Welch on Meeting with President Trump
Representatives Cummings (D-MD) and Welch (D-VT) spoke with reporters about their meeting with President Trump. They…